Try StemWave for up to 60 Days for $0

How Section 179 Could Save Your Practice Up To $17,000+ Before Year-End

Section 179 allows medical practices to deduct the entire cost of qualifying equipment purchases (up to $1.25 million in 2025) in the same tax year, rather than depreciating it over multiple years. For a practice purchasing a regenerative therapy device like StemWave, Section 179 can translate to $17,000+ in immediate tax savings for clinics typically falling within a 37 percent federal tax bracket, which can reach 40 to 44 percent when including state taxes. To qualify, equipment must be placed in service (delivered, installed, and operational) by December 31.

What Is Section 179 and Why Practice Owners Use It

Every October, November, and December, thousands of practice owners quietly reduce their tax bills by five figures using one IRS provision most accountants mention but don’t emphasize enough.

It’s called Section 179.

Under standard tax rules, capital equipment purchases depreciate slowly over several years (typically five to seven). If you buy a $100,000 device, you might only deduct $20,000 to $25,000 each year.

Section 179 changes that completely.

It lets you deduct the entire purchase price in the same year you place the equipment into service. The tax benefit is immediate, not spread across years. For practices operating in a 40 percent combined tax bracket, that’s $40,000 in real cash saved this year.

It’s not a credit you wait on. It’s not a future write-off. It’s a reduction in your current-year taxable income that directly impacts what you owe in April.

How Section 179 Works for Medical Equipment Purchases

The IRS code is straightforward: businesses can deduct the full purchase price of qualifying equipment and software placed in service during the tax year, up to $1.25 million (2025 limit). The deduction begins to phase out dollar-for-dollar once total equipment purchases exceed $3.13 million, making it most valuable for small to mid-sized practices.

Qualifying equipment includes medical devices, computers, office furniture, and vehicles used for business purposes. For healthcare practices, this typically covers regenerative therapy systems, diagnostic equipment, lasers, and other capital assets.

Key Requirements

  • Equipment must be purchased or financed (leased equipment typically doesn’t qualify)
  • Equipment must be placed in service by December 31 (delivered, installed, and operational)
  • Equipment must be used for business purposes more than 50% of the time
  • The deduction cannot exceed your practice’s taxable income for the year (you cannot use Section 179 to create a business loss)
  • Unused deductions can be carried forward to future tax years

The Installation Deadline Matters

Most providers miss this: signing paperwork or placing an order isn’t enough.

The IRS requires the equipment to be in service, meaning it’s delivered, installed, and capable of treating patients by December 31 to capture the current year’s deduction.

That’s why strategic practice owners schedule installations in early December. It locks in the deduction before the cutoff and gives adequate time for installation, training, and troubleshooting.

The Real Numbers: How Section 179 Translates Into Savings for Medical Equipment

Let’s walk through the actual math using a StemWave regenerative therapy system as the example.

Equipment cost: $100,000
Your tax bracket: 40% (combined federal and state)
Immediate tax savings: $100,000 × 0.40 = $40,000

You’re not paying $100,000 for the equipment. You’re effectively paying $60,000 after tax savings.

Tax Bracket Breakdown

Tax Bracket

Device Cost

Section 179 Savings

Effective Cost

24%

$50,000

$12,000

$38,000

32%

$50,000

$16,000

$34,000

35%

$50,000

$17,500

$32,500

37%

$50,000

$18,500

$31,500

The higher your taxable income, the greater your savings. For multi-provider practices operating in higher brackets, Section 179 becomes even more valuable.

Why Q4 Is Strategic for Equipment Purchases

Most clinics plan their biggest equipment purchases between October and December. Here’s why:

1. The December 31 Deadline

To qualify for the current year’s deduction, the device must be in service by December 31. Waiting until January means you’ve lost an entire year’s tax benefit.

2. Stacking Savings with Financing

Section 179 works with both cash purchases and financed equipment. You can deduct the full $50,000 even if you’re making monthly payments. This lets you conserve working capital while still capturing the full tax benefit.

3. Revenue Forecasting Clarity

By Q4, you have a clear picture of your annual revenue and taxable income. You know whether you can utilize the full deduction or if your income limits require planning adjustments.

4. Growth Planning for Next Year

Adding revenue-generating equipment in December means you start the new year with expanded clinical capabilities. You’re not just saving on taxes. You’re positioning your practice for growth in Q1 when patient volume typically increases.

How Section 179 Works with StemWave’s 90-Day Trial

StemWave offers a 90-Day Zero-Risk Trial, which pairs strategically with Section 179 planning.

Here’s how it works:

You schedule the installation for early December. The device is delivered, installed, and operational by mid-December, meeting the IRS in-service requirement. You test it on real patients through January, February, and March.

If StemWave doesn’t generate the clinical outcomes and patient volume you expected, you return it within 90 days. But if it performs as providers report (10-30% improvement in first sessions, $5,000-$25,000 monthly revenue increase), you keep it and capture the full Section 179 deduction.

The key: you’re not committing blind.

You’re testing the device risk-free while still qualifying for the tax benefit. By the time your accountant files in April, you’ve already validated that StemWave works in your practice.

3 Steps to Maximize Your Section 179 Savings

Step 1: Talk to Your Accountant This Week

Ask: “If I purchase qualifying medical equipment before December 31, how much would Section 179 save me based on my current taxable income?”

Your accountant can calculate your exact savings, confirm eligibility, and identify any income limitations that might affect the deduction.

Step 2: Schedule Installation Early

Don’t wait until mid-December. Equipment deliveries slow during the holidays, and installation scheduling fills up fast.

Early December installations ensure you meet the in-service deadline without last-minute stress. StemWave handles delivery, setup, staff training, and patient-flow support once paperwork is signed.

Step 3: Use the Trial Period to Validate Results

The 90-day trial isn’t just for testing technology. It’s for validating that the device generates enough patient volume and revenue to justify the investment.

Track new patient consultations, treatment protocols sold, and monthly revenue. By the end of 90 days, you’ll know whether StemWave is a practice-defining addition or something that doesn’t fit your patient base.

Common Questions About Section 179 for Medical Practices

Q: Can I use Section 179 if I finance the equipment?

A: Yes. Section 179 works with both cash purchases and financed equipment. You can deduct the full purchase price even if you’re making monthly payments. Leased equipment typically doesn’t qualify.

Q: What if my taxable income is lower than the equipment cost?

A: Your Section 179 deduction cannot exceed your practice’s taxable income for the year. You cannot use Section 179 to create a business loss. For example, if your practice has $75,000 in taxable income and you purchase $50,000 in equipment, you can deduct the full $50,000. But if you purchase $100,000 in equipment with only $75,000 in income, you can only deduct $75,000 this year. The remaining $25,000 can be carried forward to future tax years or depreciated normally.

Q: Does Section 179 apply to used equipment?

A: Yes, as long as it’s new to your practice. The equipment must be purchased (not inherited or gifted) and placed in service during the tax year.

Q: What happens if I buy equipment in December but don’t use it until January?

A: You must place the equipment in service by December 31. The IRS defines “placed in service” as delivered, installed, and ready for its intended use. Simply taking delivery without installation may not qualify.

Q: Can I combine Section 179 with bonus depreciation?

A: Yes. Section 179 is used first (up to the $1.25 million limit), and then bonus depreciation can apply to remaining qualifying purchases. For 2025, bonus depreciation is 40% (it’s phasing down from previous years and will continue decreasing until 2027 when it’s fully phased out). Consult your accountant for optimal structuring based on your total equipment purchases.

Q: Is StemWave FDA-cleared and eligible for Section 179?

A: Yes. StemWave is a Class I medical device, FDA-registered, and qualifies as capital medical equipment under Section 179 guidelines.

What This Means for Your Practice

Section 179 serves as both a tax strategy and a practice growth accelerator.

For practices stuck in the insurance grind, watching reimbursements shrink while overhead climbs, Section 179 offers a rare opportunity: reduce your tax burden while adding a cash-based revenue stream that doesn’t depend on third-party payers.

Patients are willing to pay $1,500-$2,500 for regenerative therapy protocols when conventional care has failed them. StemWave providers report adding $5,000-$25,000 per month in cash revenue within the first year.

That’s $60,000-$300,000 annually. And Section 179 helps offset the initial investment by returning $15,000-$17,500 directly to your practice via tax savings.

The December 31 Window Is Closing

If you’re considering adding regenerative therapy to your practice, the financial mechanics favor Q4 action.

Section 179 savings are immediate and substantial. The 90-day trial eliminates risk. And December installations position your practice for Q1 growth.

But the in-service deadline is non-negotiable. Once January 1 arrives, you’ve lost the current year’s tax benefit.

For practices ready to expand clinical capabilities, reduce insurance dependence, and capture a five-figure tax deduction before year-end, the decision timeline is measured in weeks, not months.

That’s where StemWave comes in.

Now, if you want to speak to a human on our team (yes, an actual human – not a chatbot), you can click the link below.

Speak To A Human (Learn More About Section 179 + StemWave) → 

Disclosure Statement: The content provided in this blog post is for informational purposes only and should not be considered financial or tax advice. Section 179 rules and limits are subject to change and may vary based on individual circumstances. Always consult with a qualified tax professional regarding your specific situation. StemWave is a Class I medical device, and individual results may vary. This post should not be interpreted as a guarantee of any specific outcome. For more information on FDA clearance and product labeling, visit the FDA’s website.

Try StemWave risk free for 60 days

Disclosure Statement: The content provided in this blog post is for informational purposes only and should not be considered medical advice. The opinions expressed are those of medical professionals and are based on a collective analysis of publicly available studies and data. Our company’s product is a Class I medical device, and while it may be related to the topics discussed in this post, it is important to note that our product may not cause similar effects as stated in the post. Additionally, this post should not be interpreted as a guarantee of any specific outcome or result. It’s important to consult with a qualified healthcare professional for personalized medical advice and treatment. We encourage readers to consult the FDA’s website for information on our product’s clearance and any relevant labeling information.

Intended Use Modus-F by StemWave: The Modus-F by StemWave, utilizing Cellular Response Technology, is intended for use in addressing minor aches and pains in accordance with the User Manual (IFU). Use of the product for any other purpose has not been reviewed by the U.S. Food and Drug Administration and is considered off-label use. Please consult the User Manual (IFU) and all labeling provided with the product prior to use.

© 2024 StemWave

Individual results may vary. Neither StemWave nor any of its subsidiaries dispense medical advice. The contents of this website do not constitute medical, legal, or any other type of professional advice. Information related to various health, medical, and fitness conditions and their treatment is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you.

Hear patients share their experience with StemWave in their pain treatment journey

Hear from medical providers about StemWave’s impact on their practice and profits

Join our Private Facebook group today!

  • Education & Training
  • Information & Resources
  • Medical Professionals Community

By using our website you agree to our